Literature DB >> 12678481

Prospective evaluation of criteria for the nonoperative management of blunt splenic trauma.

Ahmed A Meguid1, Holly A Bair, Greg A Howells, Phillip J Bendick, Hugh H Kerr, Mario R Villalba.   

Abstract

Recent reports have shown an increased mortality associated with the nonoperative management of blunt splenic injury. We have prospectively applied criteria developed from our previous 15-year experience for the nonoperative management (NOM) of blunt splenic injury. These criteria consist of 1) hemodynamic stability on admission or after initial resuscitation with up to two liters of crystalloid infusion, 2) no physical findings or any associated injuries necessitating laparotomy, and 3) a transfusion requirement attributable to the splenic injury of 2 units or less. From 1994 through 2000 a total of 99 patients presented with blunt splenic injury. Thirty-one patients (31%) underwent splenectomy secondary to hemodynamic instability. During the observation period eight of the 68 patients (12%) who initially met criteria for NOM developed hemodynamic instability and underwent splenectomy. All NOM failures occurred within 72 hours of admission. There was no mortality associated with splenic injury in the NOM (Group I) or in the group failing NOM (Group II), and no associated morbidities from the splenic injury were seen in either group. No significant differences were seen between Groups I and II in terms of age, gender, mechanism of injury, Injury Severity Score, admitting systolic blood pressure, admitting hemoglobin, transfusion requirements, intensive care unit length of stay, or total hospital length of stay (all P > 0.200). We conclude that established criteria for intervention and careful observation in an intensive care setting for at least 72 hours will minimize morbidity or mortality associated with blunt splenic injury in adults.

Entities:  

Mesh:

Year:  2003        PMID: 12678481

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  8 in total

1.  Management of blunt splenic trauma.

Authors:  Vasileios Trompetas; Andrew Sandison; Hugh Anderson
Journal:  Ann R Coll Surg Engl       Date:  2009-03       Impact factor: 1.891

2.  Blunt splenic injury and severe brain injury: a decision analysis and implications for care.

Authors:  Thamer Alabbasi; Avery B Nathens; Homer Tien
Journal:  Can J Surg       Date:  2015-06       Impact factor: 2.089

3.  Doppler ultrasound for the assessment of conservatively treated blunt splenic injuries: a prospective study.

Authors:  D Soffer; O Wiesel; C I Schulman; M Ben Haim; J M Klausner; A Kessler
Journal:  Eur J Trauma Emerg Surg       Date:  2010-09-23       Impact factor: 3.693

4.  Proximal Splenic Artery Embolization In Blunt Splenic Trauma.

Authors:  Osnat Zmora; Yitzhak Kori; David Samuels; Ada Kessler; Carl I Schulman; Joseph M Klausner; Dror Soffer
Journal:  Eur J Trauma Emerg Surg       Date:  2008-09-20       Impact factor: 3.693

5.  The song remains the same although the instruments are changing: complications following selective non-operative management of blunt spleen trauma: a retrospective review of patients at a level I trauma centre from 1996 to 2007.

Authors:  Aisling A Clancy; Corina Tiruta; Dianne Ashman; Chad G Ball; Andrew W Kirkpatrick
Journal:  J Trauma Manag Outcomes       Date:  2012-03-13

Review 6.  Literature review of non-operative management of patients with blunt splenic injury: impact of splenic artery embolization.

Authors:  Krystyn Sosada; Maciej Wiewióra; Jerzy Piecuch
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2014-07-23       Impact factor: 1.195

7.  Concurrent Surgery of Craniectomy and Splenectomy as Initial Treatment in Severe Traumatic Head Injury: A Case Report.

Authors:  Hyeong Rae Lee; Nam Kyu You; Sook Jin Seo; Mi Sun Choi
Journal:  Korean J Neurotrauma       Date:  2017-10-31

Review 8.  Splenic trauma: WSES classification and guidelines for adult and pediatric patients.

Authors:  Federico Coccolini; Giulia Montori; Fausto Catena; Yoram Kluger; Walter Biffl; Ernest E Moore; Viktor Reva; Camilla Bing; Miklosh Bala; Paola Fugazzola; Hany Bahouth; Ingo Marzi; George Velmahos; Rao Ivatury; Kjetil Soreide; Tal Horer; Richard Ten Broek; Bruno M Pereira; Gustavo P Fraga; Kenji Inaba; Joseph Kashuk; Neil Parry; Peter T Masiakos; Konstantinos S Mylonas; Andrew Kirkpatrick; Fikri Abu-Zidan; Carlos Augusto Gomes; Simone Vasilij Benatti; Noel Naidoo; Francesco Salvetti; Stefano Maccatrozzo; Vanni Agnoletti; Emiliano Gamberini; Leonardo Solaini; Antonio Costanzo; Andrea Celotti; Matteo Tomasoni; Vladimir Khokha; Catherine Arvieux; Lena Napolitano; Lauri Handolin; Michele Pisano; Stefano Magnone; David A Spain; Marc de Moya; Kimberly A Davis; Nicola De Angelis; Ari Leppaniemi; Paula Ferrada; Rifat Latifi; David Costa Navarro; Yashuiro Otomo; Raul Coimbra; Ronald V Maier; Frederick Moore; Sandro Rizoli; Boris Sakakushev; Joseph M Galante; Osvaldo Chiara; Stefania Cimbanassi; Alain Chichom Mefire; Dieter Weber; Marco Ceresoli; Andrew B Peitzman; Liban Wehlie; Massimo Sartelli; Salomone Di Saverio; Luca Ansaloni
Journal:  World J Emerg Surg       Date:  2017-08-18       Impact factor: 5.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.